TORONTO, Oct. 02, 2018 (GLOBE NEWSWIRE) --
Not for dissemination or distribution in the United States or through U.S. newswire services
Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company") is pleased to announce that it has filed a final short form prospectus (“Prospectus”) in each of the provinces of British Columbia, Alberta and Ontario to qualify the distribution of 23,376,100 units of the Company (“Units”) and the common shares and warrants underlying such Units issuable for no additional consideration upon the exercise or deemed exercise of 23,376,100 special warrants of the Company (“Special Warrants”). The Special Warrants were issued in connection with the previously announced private placement offering (the “Offering”) which closed on August 10, 2018. The Special Warrants were sold at a price of $1.60 per Special Warrant (the “Issue Price”), for aggregate gross proceeds of approximately $37.4 million.
Pursuant to the terms of the Agency Agreement, the Company agreed to use its best efforts to obtain a receipt for a final short form prospectus qualifying the distribution of the Units upon exercise of the Special Warrants (the “Qualification Condition”) on or before October 4, 2018 (the “Qualification Deadline”). The Qualification Condition was satisfied prior to the Qualification Deadline.
Pursuant to special warrant indenture dated August 10, 2018 between the Company and TSX Trust Company, each Special Warrant is exercisable, without payment of any additional consideration, on the third business day after the date on which a Final Passport System Decision Document (the “Prospectus Receipt”) is received by the Company from the Ontario Securities Commission. As the Prospectus Receipt was received by the Company on October 2, 2018, the Company expects that the deemed exercise of the Special Warrants will occur on or about October 5, 2018.
For more information on the Offering, please refer to the Prospectus, as well as the Company’s news releases, dated July 30, 2018, August 1, 2018, August 10, 2018, and August 22, 2018, available on the Company’s profile on SEDAR at www.sedar.com.
Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
About Wayland Group Corp.
Wayland is a vertically integrated producer and distributor of cannabis for medical purposes. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland. Wayland is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) footprint upon full buildout, and will continue to pursue new opportunities in Europe.
Forward Looking Statements
This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the anticipated timing of the exercise of the Special Warrants. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
For more information about Wayland, please visit our website at www.waylandgroup.com
CONTACT INFORMATION
Investor Relations
Graham Farrell
VP, Communications
Graham.Farrell@waylandgroup.com
647-643-7665
For media inquiries please contact media@waylandgroup.com
Corporate Headquarters (Canada)
Wayland Group Corp. (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3
Canada
289-288-6274
European Headquarters (Germany)
Maricann GmbH
Thierschstrasse 3, 80538 Munchen, Deutschland